This document is an excerpt from the EUR-Lex website
Document 32011M6114
Commission Decision of 24/02/2011 declaring a concentration to be compatible with the common market (Case No COMP/M.6114 - 3i GROUP / ONEMED) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)
Odločba Komisije z dne 24/02/2011 o razglasitvi združljivosti koncentracije s skupnim trgom (Zadeva št. COMP/M.6114 - 3i GROUP / ONEMED) v skladu z Uredbo Sveta (ES) št. 139/2004 (Besedilo v angleškem jeziku je edino verodostojno)
Odločba Komisije z dne 24/02/2011 o razglasitvi združljivosti koncentracije s skupnim trgom (Zadeva št. COMP/M.6114 - 3i GROUP / ONEMED) v skladu z Uredbo Sveta (ES) št. 139/2004 (Besedilo v angleškem jeziku je edino verodostojno)
In force
- Date of document:
- 24/02/2011
- Date of effect:
- 24/02/2011; začetek veljavnosti datum obvestila
- Date of end of validity:
- No end date
- Author:
- Evropska komisija, Generalni direktorat za konkurenco
- Responsible body:
- Directorate-General for Competition, COMPETITION
- Form:
- Sklep
- Addressee:
- 3i GROUP, ONEMED GROUP OY
- Additional information:
- NACE=G46 (See 32006R1893)
- Authentic language:
- angleščina
- Treaty:
- Pogodba o delovanju Evropske unije
- Legal basis:
-
- 32004R0139 - A06P1B
- Link
- Link
- Link
- Select all documents mentioning this document
- Subject matter:
- Directory code:
-
- 08.40.00.00 Politika konkurence / Koncentracije
32011M6114
Commission Decision of 24/02/2011 declaring a concentration to be compatible with the common market (Case No COMP/M.6114 - 3i GROUP / ONEMED) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)
|EUROPEAN COMMISSION | Brussels , 24.02.2011 SG-Greffe(2011) D/2851 PUBLIC VERSION C(2011) 1326 final MERGER PROCEDURE ARTICLE 6(1)(b) DECISION SIMPLIFIED PROCEDURE To the notifying party: Dear Madam(s) and/or Sir(s), Subject: Case No COMP/M.6114 - 3i GROUP/ ONEMED Notification of 20/01/2011 pursuant to Article 4 of Council Regulation (EC) No 139/2004 [1] Publication in the Official Journal of the European Union No C 29, 29/01/2011, p. 26 1. On 20/01/2011, the European Commission received notification of a proposed concentration pursuant to Article 4 of the Merger Regulation by which3i Group (United Kingdom) acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of OneMed Group Oy ("OneMed", Finland) by way of purchase of shares. The business activities of the undertakings concerned are: - 3i Group: an international investor focused on private equity, infrastructure and debt management, investing in Europe, Asia and North America; - OneMed: a wholesaler focusing on selling medical consumables to private and public health care providers in Sweden, Finland, Poland, Denmark, Norway and the Baltic countries. 2. After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger Regulation and of paragraph 5(b) of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 [2] . 3. For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article 6(1)(b) of the Merger Regulation. For the Commission (Signed) Alexander ITALIANER Director General [1]OJ L 24, 29.1.2004, p. 1 ("the Merger Regulation"). With effect from 1 December 2009, the Treaty on the Functioning of the European Union ("TFEU") has introduced certain changes, such as the replacement of "Community" by "Union" and "common market" by "internal market". The terminology of the TFEU will be used throughout this decision. [2] OJ C 56, 5.3.2005, p. 32.
